NCT05190133

Drug-drug Interaction Study Between UIC201601 and UIC201602

An Open-label, Multiple-dosing, Two-arms, One-sequence Study to Evaluate the Safety and Pharmacokinetics After Co-administration of UIC201601 and UIC201602 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Korea United Pharm. Inc. · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

An open-label, multiple-dosing, two-arms, one-sequence study to evaluate the safety and pharmacokinetics after co-administration of UIC201601 and UIC201602 in healthy male volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	UIC201602 and co-administration of UIC201601 and UIC201602	* UIC201602 4 Cap/day for 14 days * Wash out 21 days * UIC201601 4 Tab + UIC201602 4 Cap / day for 14 days
DRUG	UIC201601 and co-administration of UIC201601 and UIC201602	* UIC201601 4 Tab/day for 7 days * Wash out 14 days * UIC201601 4 Tab + UIC201602 4 Cap / day for 14 days

Timeline

• Start date: 2016-05-28
• Primary completion: 2016-08-17
• Completion: 2016-08-17
• First posted: 2022-01-13
• Last updated: 2022-01-13